相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy
Andrew J. Doyle et al.
BLOOD (2023)
First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy
Lucas Kuehne et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura
Martin Bergstrand et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpura
Lucas Kuehne et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura
Andrew J. Doyle et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Daratumumab for immune thrombotic thrombocytopenic purpura
Jana van den Berg et al.
BLOOD ADVANCES (2022)
Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura
Lars M. M. Asmis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Recombinant ADAMTS13 in Severe Neonatal Thrombotic Thrombocytopenic Purpura
Matthew J. Stubbs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Race, rituximab, and relapse in TTP
Shruti Chaturvedi et al.
BLOOD (2022)
Successful Treatment With Bortezomib for Refractory and Complicated Acquired Thrombotic Thrombocytopenic Purpura in an Adolescent Girl
Ebru Azapagasi et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2021)
Influence of Personality, Resilience and Life Conditions on Depression and Anxiety in 104 Patients Having Survived Acute Autoimmune Thrombotic Thrombocytopenic Purpura
Tanja Falter et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura
Erika Tarasco et al.
BLOOD (2021)
Redefining outcomes in immune TTP: an international working group consensus report
Adam Cuker et al.
BLOOD (2021)
Real-world experience with caplacizumab in the management of acute TTP
Tina Dutt et al.
BLOOD (2021)
Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis
Flora Peyvandi et al.
BLOOD ADVANCES (2021)
Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series
Kirstie Perrotta et al.
RHEUMATOLOGY ADVANCES IN PRACTICE (2021)
Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals
Angela Liu et al.
TRANSFUSION (2021)
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
Silvia Riva et al.
HAEMATOLOGICA (2020)
Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy
Vicky Brocklebank et al.
KIDNEY INTERNATIONAL (2020)
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment
Eric Rondeau et al.
KIDNEY INTERNATIONAL (2020)
Caplacizumab for treatment of thrombotic thrombocytopenic purpura in a patient with anaphylaxis to fresh-frozen plasma
Mehraboon S. Irani et al.
TRANSFUSION (2020)
A multi-center evaluation of TECHNOSCREEN(R) ADAMTS-13 activity assay as a screening tool for detecting deficiency of ADAMTS-13
Gary W. Moore et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Rituximab, MS, and pregnancy
Jessica B. Smith et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
Linus A. Voelker et al.
BLOOD ADVANCES (2020)
Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab
Linus A. Voelker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group
Fadi Fakhouri et al.
BLOOD (2020)
Cerebral MRI findings predict the risk of cognitive impairment in thrombotic thrombocytopenic purpura
Ferras Alwan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura
Kazuya Sakai et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
TTP in the setting of pregnancy: The story still has to be written
Paul Coppo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP
Paul Coppo et al.
BLOOD (2020)
Systemic lupus erythematosus presenting as thrombotic thrombocytopaenic purpura in a child: a diagnostic challenge
Irene Alejandra Orbe Jaramillo et al.
BMJ CASE REPORTS (2020)
Severe primary refractory thrombotic thrombocytopenic purpura (TTP) in the post plasma exchange (PEX) and rituximab era
Sowmya Goranta et al.
BMJ CASE REPORTS (2020)
Successful Management of Thrombotic Thrombocytopenic Purpura in a Jehovah's Witness: An Individualized Approach With Joint Decision-Making
Ming Y. Lim et al.
JOURNAL OF PATIENT EXPERIENCE (2020)
Rituximab-induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti-rituximab antibodies
Chiara Vendramin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Characterization and treatment of congenital thrombotic thrombocytopenic purpura
Ferras Alwan et al.
BLOOD (2019)
Comparison of the Long-Term Remission of Rituximab and Conventional Treatment for Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Review and Meta-Analysis
Weerapat Owattanapanich et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2019)
The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017
Hendrika A. van Dorland et al.
HAEMATOLOGICA (2019)
Clinical pharmacology of caplacizumab for the treatment of patients with acquired thrombotic thrombocytopenic purpura
Maria Laura Sargentini-Maier et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab
Judith Robertz et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors
Harshvardhan Upreti et al.
BLOOD (2019)
Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity
Carla Valsecchi et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Crystal structure and substrate-induced activation of ADAMTS13
Anastasis Petri et al.
NATURE COMMUNICATIONS (2019)
Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura
A. Taylor et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinical features and prognosis of patients with thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a review of 25 cases
Ji Li et al.
ITALIAN JOURNAL OF PEDIATRICS (2019)
Thrombotic thrombocytopenic purpura and defective apoptosis due to CASP8/10 mutations: the role of mycophenolate mofetil
F. Fioredda et al.
BLOOD ADVANCES (2019)
Ofatumumab for acute treatment and prophylaxis of a patient with multiple relapses of acquired thrombotic thrombocytopenic purpura
Hanny Al-Samkari et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)
Evaluation of the Fully Automated HemosIL Acustar ADAMTS13 Activity Assay
Julien Favresse et al.
THROMBOSIS AND HAEMOSTASIS (2018)
De novo thrombotic microangiopathy after kidney transplantation
Neetika Garg et al.
TRANSPLANTATION REVIEWS (2018)
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura
Matthieu Jestin et al.
BLOOD (2018)
Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab
Tanja Falter et al.
THROMBOSIS AND HAEMOSTASIS (2018)
ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman Syndrome
Berangere S. Joly et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Guidelines for the use of platelet transfusions
Lise J. Estcourt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Increased troponin I is associated with fatal outcome in acquired thrombotic thrombocytopenic purpura
Jason Brazelton et al.
JOURNAL OF CLINICAL APHERESIS (2017)
A single-center prospective study on the safety of plasma exchange procedures using a double-viral-inactivated and prion-reduced solvent/detergent fresh-frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy
Chiara Vendramin et al.
TRANSFUSION (2017)
Low level of Rituximab in human breast milk in a patient treated during lactation
Yngvill Bragnes et al.
RHEUMATOLOGY (2017)
Post-traumatic stress disorder and depression in survivors of thrombotic thrombocytopenic purpura
Shruti Chaturvedi et al.
THROMBOSIS RESEARCH (2017)
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
Pavan K. Bendapudi et al.
LANCET HAEMATOLOGY (2017)
Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah's Witness experience
James N. George et al.
BLOOD ADVANCES (2017)
Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura
Spero R. Cataland et al.
BLOOD ADVANCES (2017)
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura
Marie Scully et al.
BLOOD (2017)
Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura
Ferras Alwan et al.
BLOOD (2017)
Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens
John-Paul Westwood et al.
BLOOD ADVANCES (2017)
Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura
Christopher J. Patriquin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Flora Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Rituximab-refractory thrombotic thrombocytopenic purpura responsive to intravenous but not subcutaneous bortezomib
Priyank P. Patel et al.
TRANSFUSION (2016)
Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012
Ruchika Goel et al.
TRANSFUSION (2016)
Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer
Jordan M. Morton et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors
Suella Martino et al.
PLOS ONE (2016)
Bortezomib-based antibody depletion for refractory autoimmune hematological diseases
Sumita Ratnasingam et al.
BLOOD ADVANCES (2016)
Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura
Bowie Han et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry
Sevda Hassan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative
Pavan K. Bendapudi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
Mari R. Thomas et al.
EBIOMEDICINE (2015)
Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center
Y. Benhamou et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura
Miguel Hie et al.
BLOOD (2014)
Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes
Marie Scully et al.
BLOOD (2014)
Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib
Tessa van Balen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Conformational activation of ADAMTS13
Kieron South et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience
S. McGuckin et al.
VOX SANGUINIS (2014)
ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates
Flora Peyvandi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura
Cassandra C. Deford et al.
BLOOD (2013)
Long term outcome and sequelae in patients after acute thrombotic thrombocytopenic purpura episodes
T. Falter et al.
HAMOSTASEOLOGIE (2013)
Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse
J-P. Westwood et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
ADAMTS13 Antibody Depletion by Bortezomib in Thrombotic Thrombocytopenic Purpura
Jake Shortt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
C. M. Legendre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura
Filip Callewaert et al.
BLOOD (2012)
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center
Antoine Froissart et al.
CRITICAL CARE MEDICINE (2012)
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience
Ygal Benhamou et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom
R. S. Camilleri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Cancer-Related Microangiopathic Hemolytic Anemia Clinical and Laboratory Features in 168 Reported Cases
Klaus Lechner et al.
MEDICINE (2012)
Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience
Francois Beloncle et al.
TRANSFUSION (2012)
Pregnancy outcomes after maternal exposure to rituximab
Eliza F. Chakravarty et al.
BLOOD (2011)
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
Marie Scully et al.
BLOOD (2011)
Human immunodeficiency virus associated thrombotic thrombocytopenic purpura - favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy
Daniel Hart et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study
Carlo L. Balduini et al.
ANNALS OF HEMATOLOGY (2010)
Survival and relapse in patients with thrombotic thrombocytopenic purpura
Johanna A. Kremer Hovinga et al.
BLOOD (2010)
Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation
H. Cohen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura
V. McDonald et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
Paul Coppo et al.
PLOS ONE (2010)
Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry
V. McDonald et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Demographic and ADAMTS13 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura
Spero R. Cataland et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura
R. S. CAMILLERI et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13
C. Hughes et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome
Gema Ariceta et al.
PEDIATRIC NEPHROLOGY (2009)
Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity
Weiqiang Gao et al.
BLOOD (2008)
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
J. Evan Sadler
BLOOD (2008)
Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse
Ming Jin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
Flora Peyvandi et al.
HAEMATOLOGICA (2008)
Thrombotic thrombocytopenic purpura and systemic lupus erythematosus: Successful management of a rare presentation
Pratish George et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2008)
ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus-related thrombotic thrombocytopenic purpura
Karen Gunther et al.
TRANSFUSION (2007)
Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura
M. Scully et al.
VOX SANGUINIS (2007)
Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura
Humayun N. Ahmad et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience
Hande H. Tuncer et al.
TRANSFUSION (2007)
Outcomes in the treatment of thrombotic thrombocytopenic purpura with splenectomy: A retrospective cohort study
Ubaldo Martinez Outschoorn et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpura
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Genetics of HUS:: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
Jessica Caprioli et al.
BLOOD (2006)
ADAMTS13 substrate recognition of von Willebrand factor A2 domain
S Zanardelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura
P Coppo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS 13-deficient thrombotic thrombocytopenic purpura:: a study of 11 cases
F Fakhouri et al.
BLOOD (2005)
Splenectomy for the treatment of thrombotic thrombocytopenic purpura
MC Kappers-Klunne et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Thrombotic thrombocytopaenic purpura in HIV-infected patients
RF Miller et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2005)
The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura
BM Luken et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: one institution's experience and review of the literature
A Ziman et al.
TRANSFUSION (2005)
Non-enteropathic hemolytic uremic syndrome: Causes and short-term course
AR Constantinescu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients
SK Vesely et al.
BLOOD (2003)
Chronic relapsing thrombotic thrombocytopenic purpura in adult onset Still's disease
MGV Perez et al.
SOUTHERN MEDICAL JOURNAL (2003)
Successful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8Y
WA Lester et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Recurrent thrombotic thrombocytopenic purpura (TTP) as a complication of acute relapsing pancreatitis
JA Talwalkar et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura
F Ferrara et al.
ANNALS OF HEMATOLOGY (2002)
Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura
XL Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor
PM Mannucci et al.
BLOOD (2001)
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
GG Levy et al.
NATURE (2001)
Thrombotic thrombocytopenic purpura in acute pancreatitis
S Varadarajulu et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2000)
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): Treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases
J Dervenoulas et al.
ANNALS OF HEMATOLOGY (2000)
分享论文
